Abstract
The transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is crucial for immune responses and skeletal development. Work in recent years has shown that various members of the NF-κB family are viable targets to regulate activity and survival of bone cells and hence bone metabolism. In this regard, deletion of upstream kinases or distal NF-κB subunits resulted with bone deformities. Thus, it has become increasingly apparent that detailed investigation of NF-κB in bone cells may provide opportunities to design new therapeutic modalities. In this chapter we present modified methodology describing efficient approaches to regulate the NF-κB pathway in vitro and in vivo to assess its function in bone cells and tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abu-Amer Y (2013) NF-kappaB signaling and bone resorption. Osteoporos Int 24:2377–2386
Shiotani A, Takami M, Itoh K, Shibasaki Y, Sasaki T (2002) Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. Anat Rec 268:137–146
Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508
Boyce BF, Yao Z, Xing L (2010) Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192:367–375
Franzoso G, Carlson L, Xing L, Poljak L, Shores E, Brown K, Leonardi A, Tran T, Boyce B, Siebenlist U (1997) Requirment for NF-kappaB in osteoclast and B-cell development. Genes Dev 11:3482–3496
Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285–1289
Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:3597–3602
Boyce BF, Xing L, Franzoso G, Siebenlist U (1999) Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone 25:137–139
Abu-Amer Y (2005) Advances in osteoclast differentiation and function. Curr Drug Targets Immune Endocr Metabol Disord 5:347–355
Lamothe B, Lai Y, Xie M, Schneider MD, Darnay BG (2013) TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol 33:582–595
Hayden MS, Ghosh S (2004) Signaling to NF-κB. Genes Dev 18:2195–2224
Karin M, Yamamoto Y, Wang M (2004) The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3:17–26
Siebenlist U, Franzoso G (2001) Structure, regulation and function of NF-κB. Proc Natl Acad Sci U S A 89:4333–4337
Ting AY, Endy D (2002) Signal transduction: decoding NF-κB signaling. Science 298:1189–1190
Wong B, Lee S, Vologodskia M, Steinman R, Choi Y (1998) The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J Biol Chem 273:28335–28359
May MJ, D’Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289:1550–1554
Strickland I, Ghosh S (2006) Use of cell permeable NBD peptides for suppression of inflammation. Ann Rheum Dis 65(Suppl 3):75–82
von Bismarck P, Winoto-Morbach S, Herzberg M, Uhlig U, Schutze S, Lucius R, Krause MF (2012) IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid metabolism in a murine model. Pulm Pharmacol Ther 25:228–235
Cheng MX, Gong JP, Chen Y, Liu ZJ, Tu B, Liu CA (2012) NBD peptides protect against ischemia reperfusion after orthotopic liver transplantation in rats. J Surg Res 176:666–671
Dai S, Hirayama T, Abbas S, Abu-Amer Y (2004) The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279:37219–37222
Choi M, Rolle S, Wellner M, Cardoso MC, Scheidereit C, Luft FC, Kettritz R (2003) Inhibition of NF-κB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 102:2259–2267
Clohisy JC, Yamanaka Y, Faccio R, Abu-Amer Y (2006) Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis. J Orthop Res 24:1358–1365
Shibata W, Maeda S, Hikiba Y, Yanai A, Ohmae T, Sakamoto K, Nakagawa H, Ogura K, Omata M (2007) Cutting edge: the I{kappa}B kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J Immunol 179:2681–2685
Abu-Amer Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL (2001) TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J Biol Chem 276:30499–30503
Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4:1449–1452
Schwarze S, Ho A, Vocero-Akbani A, Dowdy S (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569–1572
Schwarze S, Hruska K, Dowdy S (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 10:290–295
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310–315
Otero JE, Chen T, Zhang K, Abu-Amer Y (2012) Constitutively active canonical NF-kappaB pathway induces severe bone loss in mice. PLoS One 7:e38694
Bloor S, Ryzhakov G, Wagner S, Butler PJ, Smith DL, Krumbach R, Dikic I, Randow F (2008) Signal processing by its coil zipper domain activates IKK gamma. Proc Natl Acad Sci U S A 105:1279–1284
Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115:565–576
Mabb AM, Wuerzberger-Davis SM, Miyamoto S (2006) PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol 8:986–993
Acknowledgments
Work in the authors’ laboratory was supported by R01 AR049192, AR054329 (NIH/NIAMS), and 85100 from the Shriners Hospital for Children.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Swarnkar, G., Abu-Amer, Y. (2015). Regulation of NF-κB Signaling in Osteoclasts and Myeloid Progenitors. In: May, M. (eds) NF-kappa B. Methods in Molecular Biology, vol 1280. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2422-6_31
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2422-6_31
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2421-9
Online ISBN: 978-1-4939-2422-6
eBook Packages: Springer Protocols